Absci Corp (ABSI) stock
ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
$8.18+0.60 (+7.92%)
Close on Nov 18, 2026Market cap $1.40BP/E –Yield –
Absci revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Absci's revenue for the twelve months ending Jun 30, 2026 was $1.56M, down 62.3% year over year. For fiscal 2025 it was $2.80M, down 38.2% from the year before. The highest annual figure on record is $5.75M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.80M | -38.2% |
| FY2024 | Dec 31, 2024 | $4.53M | -20.7% |
| FY2023 | Dec 31, 2023 | $5.72M | -0.5% |
| FY2022 | Dec 31, 2022 | $5.75M | +20.2% |
| FY2021 | Dec 31, 2021 | $4.78M | +0.0% |
| FY2020 | Dec 31, 2020 | $4.78M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $318.00K | -46.4% |
| Q1 FY2026 | Mar 31, 2026 | $215.00K | -81.8% |
| Q4 FY2025 | Dec 31, 2025 | $650.00K | -2.3% |
| Q3 FY2025 | Sep 30, 2025 | $378.00K | -77.8% |
| Q2 FY2025 | Jun 30, 2025 | $593.00K | -53.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.18M | +31.3% |
| Q4 FY2024 | Dec 31, 2024 | $665.00K | +96.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.70M | +128.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.27M | -62.3% |
| Q1 FY2024 | Mar 31, 2024 | $898.00K | -29.2% |
| Q4 FY2023 | Dec 31, 2023 | $338.00K | -78.3% |
| Q3 FY2023 | Sep 30, 2023 | $744.00K | -68.6% |
| Q2 FY2023 | Jun 30, 2023 | $3.37M | +236.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.27M | +54.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.56M | +7.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.37M | +53.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.00M | +37.6% |
| Q1 FY2022 | Mar 31, 2022 | $819.00K | -23.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.45M | -46.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.54M | +68.0% |
| Q2 FY2021 | Jun 30, 2021 | $728.00K | +29.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.06M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.73M | – |
| Q3 FY2020 | Sep 30, 2020 | $916.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $564.00K | – |
See a number that looks wrong?